| Julie L Bowman Lowe, MD | |
|
13220 N Macarthur Blvd, Oklahoma City, OK 73142-3019 | |
| (405) 608-6877 | |
| (405) 608-6899 |
| Full Name | Julie L Bowman Lowe |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 25 Years |
| Location | 13220 N Macarthur Blvd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831121672 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 24415 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Julie Bowman Lowe Md Pllc | 6406172667 | 2 |
News Archive
Fred Hutchinson Cancer Research Center scientists striving for new cancer cures - and the patients who stand to benefit from them - got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single contribution in Fred Hutch's history.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
The St. Jude Children's Research Hospital—Washington University Pediatric Cancer Genome Project found that melanoma in some adolescent and adult patients involves many of the same genetic alterations and would likely respond to the same therapy.
BELLUS Health announced today the results of the phase I clinical study for NRM8499, a prodrug of tramiprosate, intended for the treatment of Alzheimer's disease.
Research from the University of Adelaide shows middle-aged women are more likely to suffer depression from a common medical problem that they find too embarrassing to talk about: urinary incontinence.
› Verified 7 days ago
| Entity Name | Julie Bowman Lowe Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386049401 PECOS PAC ID: 6406172667 Enrollment ID: O20150305000944 |
News Archive
Fred Hutchinson Cancer Research Center scientists striving for new cancer cures - and the patients who stand to benefit from them - got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single contribution in Fred Hutch's history.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
The St. Jude Children's Research Hospital—Washington University Pediatric Cancer Genome Project found that melanoma in some adolescent and adult patients involves many of the same genetic alterations and would likely respond to the same therapy.
BELLUS Health announced today the results of the phase I clinical study for NRM8499, a prodrug of tramiprosate, intended for the treatment of Alzheimer's disease.
Research from the University of Adelaide shows middle-aged women are more likely to suffer depression from a common medical problem that they find too embarrassing to talk about: urinary incontinence.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julie L Bowman Lowe, MD Po Box 108835, Oklahoma City, OK 73101-8835 Ph: (405) 608-6877 | Julie L Bowman Lowe, MD 13220 N Macarthur Blvd, Oklahoma City, OK 73142-3019 Ph: (405) 608-6877 |
News Archive
Fred Hutchinson Cancer Research Center scientists striving for new cancer cures - and the patients who stand to benefit from them - got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single contribution in Fred Hutch's history.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
The St. Jude Children's Research Hospital—Washington University Pediatric Cancer Genome Project found that melanoma in some adolescent and adult patients involves many of the same genetic alterations and would likely respond to the same therapy.
BELLUS Health announced today the results of the phase I clinical study for NRM8499, a prodrug of tramiprosate, intended for the treatment of Alzheimer's disease.
Research from the University of Adelaide shows middle-aged women are more likely to suffer depression from a common medical problem that they find too embarrassing to talk about: urinary incontinence.
› Verified 7 days ago
Jason Matthew Hirshburg, M.D. PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: University Of Oklahoma Hsc - Dermatology, 619 N.e. 13th St, Oklahoma City, OK 73104 Phone: 405-271-4662 Fax: 405-271-4662 | |
Raymond L Cornelison, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3727 Nw 63rd St Ste 205, Oklahoma City, OK 73116 Phone: 405-608-4494 Fax: 405-608-4504 | |
Dr. Carlos Andres Garcia, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4805 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-1506 Fax: 405-636-1511 | |
Mark Stover Sullivan, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3366 Nw Expressway, Suite 720, Oklahoma City, OK 73112 Phone: 405-947-0676 Fax: 405-945-4876 | |
Dr. Brandon Rhinehart, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western, Ste 301, Oklahoma City, OK 73114 Phone: 405-947-6647 Fax: 405-948-6647 | |
Mark A Dawkins, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13174 N Macarthur Blvd, Oklahoma City, OK 73142 Phone: 405-721-5555 Fax: 405-470-7093 | |
James W Taira, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1211 N Shartel Ave, Suite 202, Oklahoma City, OK 73103 Phone: 405-235-7546 |